Table 6.
Cortical region of interest |
MwA-S (mean ± SD) |
MwA-MC (mean ± SD) |
MwA-C (mean ± SD) |
Statistics |
---|---|---|---|---|
Left primary visual cortex | 1.397 ± 0.072 | 1.489 ± 0.066 | 1.495 ± 0.063 | P = 0.003 (MwA-S vs. MwA-MC, p = 0.010; MwA-S vs. MwA-C, p = 0.006) |
Right primary visual cortex | 1.481 ± 0.106 | 1.605 ± 0.141 | 1.590 ± 0.111 | P = 0.089 |
Left secondary visual cortex | 1.754 ± 0.066 | 1.828 ± 0.073 | 1.887 ± 0.095 | P = 0.005 (MwA-S vs. MwA-C, p = 0.001) |
Right secondary visual cortex | 1.798 ± 0.056 | 1.889 ± 0.098 | 1.943 ± 0.115 | P = 0.002 (MwA-S vs. MwA-C, p = 0.002) |
Left visual area V5 | 2.332 ± 0.122 | 2.450 ± 0.141 | 2.513 ± 0.152 | P = 0.008 (MwA-S vs. MwA-C, p = 0.011) |
Right visual area V5 | 2.234 ± 0.115 | 2.331 ± 0.123 | 2.424 ± 0.201 | P = 0.010 (MwA-S vs. MwA-C, p = 0.013) |
Left somatosensory cortex BA1 | 2.015 ± 0.143 | 2.040 ± 0.105 | 2.070 ± 0.207 | P = 0.477 |
Right somatosensory cortex BA1 | 2.104 ± 0.149 | 2.190 ± 0.159 | 2.136 ± 0.178 | P = 0.436 |
Left somatosensory cortex BA2 | 2.111 ± 0.107 | 2.140 ± 0.163 | 2.217 ± 0.135 | P = 0.357 |
Right somatosensory cortex BA2 | 2.015 ± 0.123 | 2.104 ± 0.128 | 2.064 ± 0.126 | P = 0.209 |
Left somatosensory cortex BA3a | 1.622 ± 0.098 | 1.649 ± 0.077 | 1.734 ± 0.115 | P = 0.081 |
Right somatosensory cortex BA3a | 1.654 ± 0.090 | 1.704 ± 0.100 | 1.745 ± 0.082 | P = 0.040 (MwA-S vs. MwA-C, p = 0.009) |
Left somatosensory cortex BA3b | 1.725 ± 0.116 | 1.814 ± 0.055 | 1.859 ± 0.129 | P = 0.014 (MwA-S vs. MwA-C, p = 0.017) |
Right somatosensory cortex BA3b | 1.583 ± 0.116 | 1.605 ± 0.106 | 1.613 ± 0.134 | P = 0.663 |
Left BA44 | 2.558 ± 0.137 | 2.628 ± 0.105 | 2.659 ± 0.129 | P = 0.190 |
Right BA44 | 2.502 ± 0.105 | 2.555 ± 0.076 | 2.615 ± 0.153 | P = 0.117 |
Left BA45 | 2.409 ± 0.088 | 2.451 ± 0.165 | 2.512 ± 0.148 | P = 0.246 |
Right BA45 | 2.440 ± 0.139 | 2.522 ± 0.132 | 2.548 ± 0.165 | P = 0.135 |
MACS, Migraine Aura Complexity Score; BA, Brodmann area; MwA-S, patients who have migraine with simple auras; MwA-MC, patients who have migraine with moderately complex auras; MwA-C, patients who have migraine with complex auras.